Halozyme Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Citigroup
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $18M | 21M | 0.86 |
2023-09-30 | $18M | 21M | 0.84 |
2023-03-31 | $17M | 21M | 0.85 |
2022-12-31 | $20M | 20M | 0.97 |
2022-09-30 | $17M | 21M | 0.85 |